مقالات ISI گوستو (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Establishment of the nasal microbiota in the first 18Â months of life: Correlation with early-onset rhinitis and wheezing
Keywords: گوستو; Rhinitis; wheeze; eczema; infant; cesarean section; nasal microbiota; 16S rRNA gene; Aerococcaceae; Corynebacteriaceae; Oxalobacteraceae; Staphylococcaceae; Moraxellaceae; EMIRGE; Expectation Maximization Iterative Reconstruction of Genes from the Environ
Low Food Allergy Prevalence Despite Delayed Introduction of Allergenic Foods-Data from the GUSTO Cohort
Keywords: گوستو; Food allergy; Allergy prevention; Solids introduction; Allergenic food introduction; Complementary feeding; Egg; Milk; Peanut; GUSTO; Growing Up in Singapore Towards healthy Outcomes; OR; Odds ratio; SPT; Skin prick test;
Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
Keywords: گوستو; ACS; acute coronary syndrome; ACCOAST trial; Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pretreatment at the Time of Diagnosis in Patients with Non-ST Elevation Myocardial Infarction trial; ACUITY; acute catheterization
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Keywords: گوستو; antiplatelet therapy; bleeding; coronary artery disease; outcomes; CHAMPION; Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition; CI; confidence interval; GPI; glycoprotein IIb/IIIa inhibitor; GUSTO; Global Use of Strate
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial
Keywords: گوستو; ACS; acute coronary syndromes; CABG; coronary artery bypass grafting; CI; confidence interval; GUSTO; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; IDR; ischemia-driven revascularization; MI; myocardi
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome
Keywords: گوستو; ACC; American College of Cardiology; ACS; acute coronary syndrome; AHA; American Heart Association; BMS; bare metal stent; CI; contraindication; CKD; chronic kidney disease; CTO; chronic total occlusion; DAPT; dual antiplatelet therapy; DES; drug-eluting
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial
Keywords: گوستو; aspirin; Bleeding Academic Research Consortium; clopidogrel; mortality; vorapaxar; BARC; Bleeding Academic Research Consortium; CABG; coronary artery bypass graft; CI; confidence interval; eCRF; electronic case report form; GUSTO; Global Use of Strategies
DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction
Keywords: گوستو; coronary stenting; dual antiplatelet therapy; percutaneous coronary intervention; ACS; acute coronary syndrome(s); DAPT; Dual Antiplatelet Therapy; GUSTO; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries; HR; haza
Sleep duration and growth outcomes across the first two years of life in the GUSTO study
Keywords: گوستو; BISQ; Brief Infant Sleep Questionnaire; BMI; body mass index; GUSTO; Growing Up in Singapore Towards healthy Outcomes; Sleep duration; Children; Growth; Body mass index; Body length; Cohort study;
Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin: Insights From the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI])
Keywords: گوستو; bivalirudin; cangrelor; CHAMPION PHOENIX; stent thrombosis; CI; confidence interval; GUSTO; Global Use of Strategies to Open Occluded Arteries; IDR; ischemia-driven revascularization; MI; myocardial infarction; mITT; modified intention-to-treat; NSTE-ACS;
Olfatto e gusto
Keywords: گوستو; Olfatto; Gusto; Recettori; Bulbo olfattivo; Tratto olfattivo; Nucleo gustativo;
Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care
Keywords: گوستو; ACC; American College of Cardiology; AHA; American Heart Association; CABG; coronary artery bypass grafting; CI; confidence interval; CLARITY; Clopidogrel as Adjunctive Reperfusion Therapy; COMMIT; Clopidogrel and Metoprolol in Myocardial Infarction Trial
Acute Coronary Syndromes: Diagnosis and Management, Part II
Keywords: گوستو; ACC; American College of Cardiology; ACE; angiotensin-converting enzyme; ACS; acute coronary syndrome; AHA; American Heart Association; APTT; activated partial thromboplastin time; ASSENT; Assessment of the Safety of a New Thrombolytic; CABG; coronary art
Esplorazione funzionale e disturbi del gusto
Keywords: گوستو; Gusto; Elettrogustometria; Potenziali evocati gustativi; Magnetoencefalografia; RM funzionale; Tomografia a emissione di positroni;
Patients With Prolonged Ischemic Chest Pain and Presumed-New Left Bundle Branch Block Have Heterogeneous Outcomes Depending on the Presence of ST-Segment Changes
Keywords: گوستو; AMI; acute myocardial infarction; CI; confidence interval; CK; creatine kinase; GUSTO; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; HERO; Hirulog and Early Reperfusion or Occlusion; LBBB; left bundle